Tofu at least once weekly,
does it really help with Lower incidence of coronary heart disease?
research showsThe grade is C. People reporting tofu at least once weekly had lower coronary heart disease incidence than those reporting less than once monthly, HR 0.82, 95% CI 0.70 to 0.95. This was an observational cohort, not a trial assigning tofu, so causation is not established.
ads claimThe accurate statement is that lower incidence occurred among people reporting frequent tofu intake. Saying that feeding tofu prevented coronary disease turns observation into experiment.
Useful facts when choosing a product
- Tofu does contain isoflavones. In the USDA database, one category of firm silken tofu averaged 29.97 mg total isoflavones per 100 g, with substantial variation across products.
- The 29.97 mg per 100 g value is a general measurement for USDA samples, not a direct assay of tofu eaten by cohort participants.
- The presence of isoflavones does not establish that tofu acts identically to human estrogen.
- The cohorts were supported by NIH grants, and no soy-association funding was identified.
- Verdict 063 is C with 46 points for isolated soy isoflavones and menopausal symptoms, while verdict 513 is C with 58 points for soy protein and LDL reduction. Their interventions and outcomes differ from whole tofu and coronary incidence here.
- Tofu has a long East Asian food history, but no exact classical date or quotation was verified.
What the research actually shows
The 2020 Circulation paper, supplement, and HPFS dietary-validation report were cross-checked. Nonfatal myocardial infarction and coronary death were adjudicated from medical and death records. The 0.56 correlation with diet records applied to a combined tofu and soybean item, not tofu alone. Bias concerns include self-reported food-frequency exposure, limited item validity, residual confounding by health behavior and education, and multiple comparisons across tofu, soy milk, isoflavones, and female subgroups.
Why this is classified as C (48)
A publicly funded large prospective observational cohort found a binary clinical endpoint association whose confidence interval excluded 1. Self-reported food-frequency exposure, limited item validity, residual confounding by health behavior and education, and multiple comparisons raise the bias level, yielding C with 48 points.
Counterpoint. A long trial assigning tofu replacement against another protein source would be more direct but difficult to conduct for coronary events.
Rejudgment record. Cross-check applied — Assessed adjudicated events, confidence intervals excluding 1, self-reported food-frequency exposure, validity of the combined tofu and soybean item, residual confounding, and multiple comparisons
| Endpoint | H | Hard endpoint - actual events such as death |
| Replication | R1 | Single confirmatory trial |
| Independence | I2 | Decisive evidence is publicly or non-profit funded |
| Effect size | E+ | Meets the clinically important threshold |
The scoring table and the verdict agree (C).
Sub-claim grades by effect
This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.
| Effect (sub-claim) | Grade | Basis |
|---|---|---|
| Eating tofu at least weekly prevents coronary heart disease | C | An inverse association was observed, but causation is unconfirmed. |
| Tofu contains isoflavones | C | This is a verified composition fact, separate from coronary efficacy. |
Cross-check — Codex and Claude
Evidence Table
| Study | Design | Sample | Funding | Endpoint | Result | Weight |
|---|---|---|---|---|---|---|
| Study 1 | Pooled observational analysis of three prospective cohorts | 8,359 | US National Institutes of Health | Nonfatal myocardial infarction or coronary heart disease death | At least weekly versus less than monthly tofu HR 0.82 (0.70 to 0.95); confidence interval excluded 1 | Large clinical-endpoint analysis, but a single observational cohort |
Receipt — 3 References
All 3 cited sources were verified for existence at the original page (as of 2026-08-03).
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-08-03 · Corrections: none
Cite this verdict
[Chamgap] Tofu at least once weekly x lower coronary heart disease incidence — Evidence Grade C·48. 3 cited sources checked. Source: https://chamgap.com/en/verdicts/heart/tofu-weekly-coronary-heart-disease-incidence/ · CC BY 4.0CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.
What this document does and does not do
Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.